Happy Belly Food Group Inc. (CSE:HBFG)

CTI BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	132	147	26	10	19	36
Market Cap Growth	370.22%	470.31%	147.58%	-44.41%	-47.73%	123.14%
Enterprise Value	134	150	30	11	18	35
Last Close Price	1.02	1.22	0.24	0.10	0.18	0.53
PS Ratio	12.24	16.26	4.78	3.82	15.04	351.88
PB Ratio	45.26	60.67	-46.14	13.27	6.11	8.00
P/TBV Ratio	153.81	209.55	-	-	14.88	8.38
EV/Sales Ratio	12.45	16.49	5.47	4.19	14.19	342.27
Debt / Equity Ratio	1.90	2.14	-9.53	3.69	0.11	0.02
Asset Turnover	1.18	1.19	1.07	0.69	0.28	0.03
Inventory Turnover	13.97	13.95	10.10	7.46	7.50	-
Quick Ratio	2.40	2.98	1.37	1.59	3.59	5.52
Current Ratio	2.84	3.28	1.59	1.94	4.22	6.17
Return on Equity (ROE)	-129.36%	-242.32%	-1616.38%	-142.06%	-702.47%	-156.71%
Return on Assets (ROA)	-8.44%	-11.11%	-13.38%	-29.93%	-154.70%	-75.41%
Return on Capital (ROIC)	-10.84%	-13.59%	-16.01%	-33.50%	-173.78%	-89.03%
Earnings Yield	-1.80%	-1.60%	-7.43%	-26.27%	-141.49%	-12.19%
FCF Yield	-0.69%	-0.70%	-4.16%	-16.52%	-22.26%	-5.00%
Buyback Yield / Dilution	-15.02%	-11.39%	-2.43%	-7.54%	-136.44%	-60.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.